Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels
24/7 Wall St
Sun, 06/7/15 - 10:57 am
FDA
advisory panels
Regeneron
AbbVie
Amgen
Repatha
alirocumab
PCSK9 inhibitors
The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week
Barron's
Fri, 06/5/15 - 12:22 pm
FDA
advisory panels
Regeneron
Sanofi
Amgen
PCSK9 inhibitors
Praluent
Amgen Subpoenas a Journalist as it Fights a Shareholder Lawsuit
WSJ Pharmalot
Thu, 06/4/15 - 08:17 pm
Amgen
journalists
shareholders
Aranesp
Novartis tries to get U.S. ban lifted on sale of Neupogen copycat
Yahoo/Reuters
Wed, 06/3/15 - 07:37 pm
Novartis
Neupogen
biosimilars
Zarxio
Amgen
Sandoz
Amgen: The Quiet Winner
Barron's
Wed, 06/3/15 - 12:36 pm
Amgen
ASCO
Kyprolis
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
Yahoo
Tue, 06/2/15 - 09:15 am
Amgen
Roche
triple negative breast cancer
Talimogene Laherparepvec
atezolizumab
colorectal cancer
For The Pricing Of New Cholesterol Lowering PCSK-9 Drugs, Does Dose Size Matter?
Forbes
Mon, 06/1/15 - 12:16 pm
PCSK9 inhibitors
drug pricing
Amgen
Sanofi
Regeneron
Pfizer
Amgen preps an FDA pitch for its late-stage kidney drug
Fierce Biotech
Fri, 05/29/15 - 11:07 am
Amgen
FDA
AMG 416
Big Pharma and Insurers Play Nice
Bloomberg
Fri, 05/29/15 - 11:00 am
Big Pharma
insurers
Amgen
5 Drugs That Could Be Summer Blockbusters
Investors.com
Wed, 05/27/15 - 11:06 am
Valeant Pharmaceuticals
Actavis
Xifaxan
Orkambi
Vertex Pharmaceuticals
Regeneron
Sanofi
Amgen
Repatha
eluxadoline
Praluent
A Review Of Amgen's AMG 334
Seeking Alpha
Wed, 05/27/15 - 10:01 am
Amgen
migraines
AMG-334
Amgen Gets 1 Step Closer to Another Blockbuster
Investopedia
Wed, 05/27/15 - 09:19 am
Amgen
Repatha
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Gilead Sciences
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
drug pricing
Repatha
Praluent
AstraZeneca’s Prospects Weaken as Amgen Exits Drug Partnership
Bloomberg
Tue, 05/26/15 - 09:51 am
AstraZeneca
Amgen
Fight over hot new cholesterol drugs may be won in milligrams
Yahoo/Reuters
Tue, 05/26/15 - 09:37 am
Amgen
Repatha
Regeneron
Sanofi
Praluent
The Most Loved Biotechs of Big Hedge Funds
24/7 Wall St
Sat, 05/23/15 - 11:41 am
biotech
Pharmacyclics
Gilead Sciences
Regeneron
Celgene
Amgen
Amgen ends collaboration with AstraZeneca on inflammation drug
Yahoo/Reuters
Fri, 05/22/15 - 06:40 pm
Amgen
AstraZeneca
inflammation
A Beautiful Biotech Summer?
Barron's
Fri, 05/22/15 - 06:39 pm
biotech
Biogen
Alexion
Amgen
Celgene
Regeneron
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
BioPharma Dive
Thu, 05/21/15 - 08:47 am
Amgen
PCSK9 inhibitor
Repatha
Europe
Sanofi
Regeneron
Praluent
Pages
« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »